⌘K

Login Start Free

Horizon Therapeutics Public Ltd Co·4

Oct 2, 7:32 PM ET

Watkins Thomas 4

4 · Horizon Therapeutics Public Ltd Co · Filed Oct 2, 2023

Insider Transaction Report

Form 4

Period: 2023-09-29

Horizon Therapeutics Public Ltd CoHZNP

Director

Transactions

Exercise/Conversion
Stock Option (right to buy)
2023-09-29−20,000→ 0 total
Exercise: $15.96Exp: 2024-06-26→ Ordinary shares (20,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2023-09-29−21,323→ 10,838 total
Exercise: $13.87Exp: 2028-05-02→ Ordinary shares (21,323 underlying)
Exercise/Conversion
Stock Option (right to buy)
2023-09-29−40,000→ 0 total
Exercise: $12.29Exp: 2024-04-14→ Ordinary shares (40,000 underlying)
Exercise/Conversion
Ordinary Shares
2023-09-29$12.29/sh+40,000$491,600→ 69,124 total
Exercise/Conversion
Ordinary Shares
2023-09-29$13.87/sh+21,323$295,750→ 110,447 total
Exercise/Conversion
Ordinary Shares
2023-09-29$15.96/sh+20,000$319,200→ 89,124 total

Holdings

Ordinary Shares
(indirect: By Partnership)
10,000
Ordinary Shares
(indirect: By Trust)
55,953

Footnotes (1)

[F1]The stock option is fully vested.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION